Venus Medtech Company Top Insiders

VMTHF Stock  USD 0.27  0.03  10.00%   
Venus Medtech employs about 1 K people. The company is managed by 9 executives with a total tenure of roughly 2425 years, averaging almost 269.0 years of service per executive, having 115.44 employees per reported executive. Examination of Venus Medtech's management performance can provide insight into the company performance.
Shakeel Osman  Insider
VP Europe
Haiyue Ma  Insider
CFO Sec
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Venus Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Venus Medtech Management Team Effectiveness

The company has return on total asset (ROA) of (0.0486) % which means that it has lost $0.0486 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1052) %, meaning that it generated substantial loss on money invested by shareholders. Venus Medtech's management efficiency ratios could be used to measure how well Venus Medtech manages its routine affairs as well as how well it operates its assets and liabilities.

Venus Medtech Workforce Comparison

Venus Medtech is rated first in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 5,274. Venus Medtech retains roughly 1,039 in number of employees claiming about 20% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (1.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.18) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.18.

Venus Medtech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Venus Medtech Price Series Summation is a cross summation of Venus Medtech price series and its benchmark/peer.

Venus Medtech Notable Stakeholders

A Venus Medtech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Venus Medtech often face trade-offs trying to please all of them. Venus Medtech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Venus Medtech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Venus Medtech Management Performance

The success or failure of an entity such as Venus Medtech often depends on how effective the management is. Venus Medtech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Venus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Venus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Venus Medtech Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company was founded in 2009 and is headquartered in Hangzhou, the Peoples Republic of China. Venus Medtech operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 905 people.

Venus Medtech Workforce Analysis

Traditionally, organizations such as Venus Medtech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Venus Medtech within its industry.

Venus Medtech Manpower Efficiency

Return on Venus Medtech Manpower

Revenue Per Employee400.3K
Revenue Per Executive46.2M
Net Loss Per Employee359.6K
Net Loss Per Executive41.5M

Complementary Tools for Venus Pink Sheet analysis

When running Venus Medtech's price analysis, check to measure Venus Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Venus Medtech is operating at the current time. Most of Venus Medtech's value examination focuses on studying past and present price action to predict the probability of Venus Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Venus Medtech's price. Additionally, you may evaluate how the addition of Venus Medtech to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios